Toronto Dominion Bank’s Japer Therapeutics Warrants JSPRW Stock Holding History

Toronto Dominion Bank’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.4K	Sell	2,174,682 -100	-0%	-$2	﹤0.01%	1973
2026 Q1	$47.8K	Sell	2,174,782 -31,828	-1%	-$1.03K	﹤0.01%	1777
2025 Q4	$88.3K	Buy	2,206,610 +38,841	+2%	+$4.38K	﹤0.01%	1581
2025 Q3	$173K	Sell	2,167,769 -2,503	-0.1%	-$213	﹤0.01%	1417
2025 Q2	$271K	Buy	+2,170,272	New	+$232K	﹤0.01%	1258

Other funds holding JSPRW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Toronto Dominion Bank's JSPRW Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Japer Therapeutics Warrants (JSPRW) stake by 0% in Q2 2026, selling an estimated $2 and leaving 2,174,682 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Toronto Dominion Bank first reported a position in JSPRW in Q2 2025 and has held it in 5 quarters since. The position peaked at $271K in Q2 2025. 6 funds tracked by Wall St. Rank hold JSPRW as of Q2 2026.

Toronto Dominion Bank held 2,174,682 shares of Japer Therapeutics Warrants worth $30.4K as of Q2 2026.
Toronto Dominion Bank sold 100 Japer Therapeutics Warrants shares in Q2 2026, an estimated $2.
Japer Therapeutics Warrants made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1973 holding.
Toronto Dominion Bank first reported a position in Japer Therapeutics Warrants in Q2 2025 and has held it in 5 quarters since.
Toronto Dominion Bank's Japer Therapeutics Warrants position peaked at $271K in Q2 2025.
6 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.